159 related articles for article (PubMed ID: 32240908)
1. SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach.
de Veij Mestdagh PD; Walraven I; Vogel WV; Schreuder WH; van Werkhoven E; Carbaat C; Donswijk ML; van den Brekel MWM; Al-Mamgani A
Radiother Oncol; 2020 Jun; 147():56-63. PubMed ID: 32240908
[TBL] [Abstract][Full Text] [Related]
2. Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial.
de Veij Mestdagh PD; Schreuder WH; Vogel WV; Donswijk ML; van Werkhoven E; van der Wal JE; Dirven R; Karakullukcu B; Sonke JJ; van den Brekel MWM; Marijnen CAM; Al-Mamgani A
BMC Cancer; 2019 Nov; 19(1):1110. PubMed ID: 31727019
[TBL] [Abstract][Full Text] [Related]
3. SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma.
de Veij Mestdagh PD; Jonker MCJ; Vogel WV; Schreuder WH; Donswijk ML; Klop WMC; Al-Mamgani A
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2135-2144. PubMed ID: 29955968
[TBL] [Abstract][Full Text] [Related]
4. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
[TBL] [Abstract][Full Text] [Related]
5. Incidence of contralateral regional failure in the electively irradiated contralateral neck of patients with head and neck squamous cell carcinoma.
de Veij Mestdagh PD; van Werkhoven E; Navran A; de Boer JP; Schreuder WH; Vogel WV; Al-Mamgani A
Clin Transl Radiat Oncol; 2019 Jul; 17():7-13. PubMed ID: 31061901
[TBL] [Abstract][Full Text] [Related]
6. Individualized Prophylactic Neck Irradiation in Patients with cN0 Head and Neck Cancer Based on Sentinel Lymph Node(s) Identification: Definitive Results of a Prospective Phase 1-2 Study.
Longton E; Lawson G; Bihin B; Mathieu I; Hanin FX; Deheneffe S; Vander Borght T; Laloux M; Daisne JF
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(4):652-661. PubMed ID: 32294522
[TBL] [Abstract][Full Text] [Related]
7. Personalized neck irradiation guided by sentinel lymph node biopsy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx with a clinically negative neck: (Chemo)radiotherapy to the PRIMary tumor only. Protocol of the PRIMO study.
van den Bosch S; Takes RP; de Ridder M; de Bree R; Al-Mamgani A; Schreuder WH; Hoebers FJP; van Weert S; Elbers JBW; Hardillo JA; Meijer TWH; Plaat BEC; de Jong MA; Jansen JC; Wellenstein DJ; van den Broek GB; Vogel WV; Arens AIJ; Kaanders JHAM
Clin Transl Radiat Oncol; 2024 Jan; 44():100696. PubMed ID: 37965060
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Quality-of-Life Following Involved Nodal Radiotherapy for Head and Neck Squamous Cell Carcinoma: The INRT-AIR Phase II Clinical Trial.
Sher DJ; Moon DH; Vo D; Wang J; Chen L; Dohopolski M; Hughes R; Sumer BD; Ahn C; Avkshtol V
Clin Cancer Res; 2023 Sep; 29(17):3284-3291. PubMed ID: 37363993
[TBL] [Abstract][Full Text] [Related]
9. Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: A paradigm shift.
Al-Mamgani A; Verheij M; van den Brekel MWM
Eur J Cancer; 2017 Sep; 82():1-5. PubMed ID: 28633075
[TBL] [Abstract][Full Text] [Related]
10. Evaluating contralateral neck failure in patients with lateralized OPSCC treated with transoral robotic surgery and neck management based on pre-operative SPECT-CT lymphatic mapping.
Berania I; Hosni A; Thomas CM; Goldstein D; Bayley A; Mohan R; Hendler A; Cooper RM; de Almeida JR
J Otolaryngol Head Neck Surg; 2022 Dec; 51(1):47. PubMed ID: 36575528
[TBL] [Abstract][Full Text] [Related]
11. Ipsilateral irradiation for well lateralized carcinomas of the oral cavity and oropharynx: results on tumor control and xerostomia.
Cerezo L; Martín M; López M; Marín A; Gómez A
Radiat Oncol; 2009 Sep; 4():33. PubMed ID: 19723329
[TBL] [Abstract][Full Text] [Related]
12. Single-Arm Phase 2 Trial of Elective Nodal Dose Reduction for Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.
Maguire PD; Neal CR; Hardy SM; Schreiber AM
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1210-1216. PubMed ID: 29452770
[TBL] [Abstract][Full Text] [Related]
13. Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
van den Bosch S; Dijkema T; Kunze-Busch MC; Terhaard CH; Raaijmakers CP; Doornaert PA; Hoebers FJ; Vergeer MR; Kreike B; Wijers OB; Oyen WJ; Kaanders JH
BMC Cancer; 2017 Mar; 17(1):208. PubMed ID: 28327089
[TBL] [Abstract][Full Text] [Related]
14. Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy.
Kaae JK; Johnsen L; Hansen CR; Kristensen MH; Brink C; Eriksen JG
Acta Oncol; 2019 Oct; 58(10):1366-1372. PubMed ID: 31241381
[No Abstract] [Full Text] [Related]
15. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
[TBL] [Abstract][Full Text] [Related]
16. SPECT/CT lymphoscintigraphy of sentinel node(s) for superselective prophylactic irradiation of the neck in cN0 head and neck cancer patients: a prospective phase I feasibility study.
Daisne JF; Installé J; Bihin B; Laloux M; Vander Borght T; Mathieu I; Lawson G
Radiat Oncol; 2014 May; 9():121. PubMed ID: 24885222
[TBL] [Abstract][Full Text] [Related]
17.
van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
[TBL] [Abstract][Full Text] [Related]
18. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance guided elective neck irradiation targeting individual lymph nodes: A new concept.
Reinders FCJ; Heijst TCFV; Mases J; Terhaard CHJ; Doornaert PAH; Philippens MEP; Raaijmakers CPJ
Phys Imaging Radiat Oncol; 2021 Oct; 20():76-81. PubMed ID: 35169639
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial.
Gupta T; Sinha S; Ghosh-Laskar S; Budrukkar A; Mummudi N; Swain M; Phurailatpam R; Prabhash K; Agarwal JP
Radiat Oncol; 2020 Sep; 15(1):218. PubMed ID: 32938468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
